Maxillary Mucormycosis Osteomyelitis in Post COVID-19 Patients: A Series of Fourteen Cases
During the current pandemic of COVID-19, numerous manifestations and complications have developed. Patients with COVID-19 are at high risk of fungal infections, such as mucormycosis, that may result directly from COVID-19 infection and/or as a side effect of the drugs used in COVID-19 treatment prot...
Guardado en:
Autores principales: | Wael M. Said Ahmed, Amira M. Elsherbini, Nehal M. Elsherbiny, Mohamed El-Sherbiny, Nevine I. Ramzy, Ahmed F. Arafa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f6798344fef43be9efcf89ba238799a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Maxillary Osteomyelitis by Actinomyces in a Child
por: Neto,Nicolau Conte, et al.
Publicado: (2018) -
Chronic Osteomyelitis of the Maxilla and Mandible: Microbiological and Clinical Aspects
por: Gaetti-Jardim Júnior,Elerson, et al.
Publicado: (2010) -
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
por: Junyan Qu, et al.
Publicado: (2021) -
Chronic Suppurative Osteomyelitis of the Mandible Treated with Antibiotics Complemented with Surgical Treatment: A Case Report
por: Barajas-Pérez,Víctor Hiram, et al.
Publicado: (2017) -
Rhino-orbito-cerebral Mucormycosis: Pictorial Review
por: Vivek Pai, et al.
Publicado: (2021)